534 related articles for article (PubMed ID: 33013918)
1. Female Gut and Genital Tract Microbiota-Induced Crosstalk and Differential Effects of Short-Chain Fatty Acids on Immune Sequelae.
Amabebe E; Anumba DOC
Front Immunol; 2020; 11():2184. PubMed ID: 33013918
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
3. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
4. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
[TBL] [Abstract][Full Text] [Related]
5. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
Morrison DJ; Preston T
Gut Microbes; 2016 May; 7(3):189-200. PubMed ID: 26963409
[TBL] [Abstract][Full Text] [Related]
6. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
[TBL] [Abstract][Full Text] [Related]
7. SCFA: mechanisms and functional importance in the gut.
Martin-Gallausiaux C; Marinelli L; Blottière HM; Larraufie P; Lapaque N
Proc Nutr Soc; 2021 Feb; 80(1):37-49. PubMed ID: 32238208
[TBL] [Abstract][Full Text] [Related]
8. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
[TBL] [Abstract][Full Text] [Related]
10. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
11. Physiological Role of Gut Microbiota for Maintaining Human Health.
Andoh A
Digestion; 2016; 93(3):176-81. PubMed ID: 26859303
[TBL] [Abstract][Full Text] [Related]
12. Connection between gut microbiome and the development of obesity.
Zhi C; Huang J; Wang J; Cao H; Bai Y; Guo J; Su Z
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):1987-1998. PubMed ID: 31367997
[TBL] [Abstract][Full Text] [Related]
13. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
14. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
[TBL] [Abstract][Full Text] [Related]
15. Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.
Marizzoni M; Cattaneo A; Mirabelli P; Festari C; Lopizzo N; Nicolosi V; Mombelli E; Mazzelli M; Luongo D; Naviglio D; Coppola L; Salvatore M; Frisoni GB
J Alzheimers Dis; 2020; 78(2):683-697. PubMed ID: 33074224
[TBL] [Abstract][Full Text] [Related]
16. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
17. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
18. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
19. The role of short-chain fatty acids in microbiota-gut-brain communication.
Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
[TBL] [Abstract][Full Text] [Related]
20. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases.
Rasouli-Saravani A; Jahankhani K; Moradi S; Gorgani M; Shafaghat Z; Mirsanei Z; Mehmandar A; Mirzaei R
Biomed Pharmacother; 2023 Jun; 162():114620. PubMed ID: 37004324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]